Intraoperative near-infrared fluorescence guided surgery using indocyanine green (ICG) may aid the surgical removal of benign bone and soft tissue tumours.
Marcus J BrookesCorey D ChanTimothy P CrowleyManiram RagbirKanishka M GhoshThomas BeckingsaleKenneth S RankinPublished in: Surgical oncology (2024)
The use of ICG for fluorescence guided surgery is a promising technology to improve outcomes of surgery for benign bone and soft tissue tumours. Further, longer term, study with a control arm is needed to identify whether it results in a reduction in the local recurrence rate.
Keyphrases
- soft tissue
- minimally invasive
- coronary artery bypass
- surgical site infection
- single molecule
- preterm infants
- percutaneous coronary intervention
- type diabetes
- patients undergoing
- metabolic syndrome
- coronary artery disease
- bone loss
- energy transfer
- acute coronary syndrome
- skeletal muscle
- photodynamic therapy
- glycemic control
- postmenopausal women